Evidence map›Paper›PMID 37743956›Full record

ArticlePEC innovation2023

Developing, optimizing, and evaluating patient infographics for diagnosing cardiac amyloidosis.

Allison P Pack, Andrea Zuleta, Eleanor Daugerdas, Wei Huang, Stephanie Batio, Sophia Svoboda, Emily P Zeitler, Nisith Kumar, Stephen Watt, Maria Isabel Fernandez-Arias and 3 more

Abstract read
In one paragraph

Article in PEC innovation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Allison P PackDivision of General Internal Medicine, Feinberg School of Medicine at Northwestern University, United States of America.
Andrea ZuletaDivision of General Internal Medicine, Feinberg School of Medicine at Northwestern University, United States of America.
Eleanor DaugerdasDivision of General Internal Medicine, Feinberg School of Medicine at Northwestern University, United States of America.
Wei HuangDivision of General Internal Medicine, Feinberg School of Medicine at Northwestern University, United States of America.
Stephanie BatioDivision of General Internal Medicine, Feinberg School of Medicine at Northwestern University, United States of America.
Sophia SvobodaDivision of General Internal Medicine, Feinberg School of Medicine at Northwestern University, United States of America.
Emily P ZeitlerDartmouth Hitchcock Medical Center, Heart and Vascular Center, Cardiovascular Section, The Dartmouth Institute, Geisel School of Medicine at Dartmouth, United States of America.
Nisith KumarPfizer, Inc, United States of America.
Stephen WattPfizer, Inc, United States of America.
Maria Isabel Fernandez-AriasPfizer, Limited, Spain.
Mehnaz BaderPfizer, Inc, United States of America.
Annlouise R AssafPfizer, Inc, United States of America.
Stacy Cooper BaileyDivision of General Internal Medicine, Feinberg School of Medicine at Northwestern University, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Advancements in diagnostics and treatment options for cardiac amyloidosis have improved patient outcomes, yet few patient education materials exist to help patients understand the disease and diagnosis process. We sought to develop and evaluate a set of plain language, patient-centered infographics describing the condition and common diagnostic tests. Methods: Using health literacy best practices, we developed 7 infographics which were further revised based on multilevel stakeholder feedback. To evaluate the materials, we recruited 100 patients from healthcare settings in Chicago, IL; participants completed a web-assisted interview during which they were randomized 1:1 to first view either our infographics or a standard material. Participants completed a knowledge assessment on their assigned material and subsequently reported impressions of both materials. Results: No differences were found between study arms in knowledge. The infographics took significantly less time to read and were more highly rated by participants in terms of appearance and understandability. Over two-thirds of participants preferred the infographics to the standard. Conclusions: The infographics created may improve the learning process about a complex condition and diagnosis process unknown to most adults. Innovation: These infographics are the first of their kind for cardiac amyloidosis and were created using health literacy best practices.

Indexed as

Cardiac amyloidosisHealth literacyPatient education

Identifiers

PMID37743956
PMCPMC10514075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.